Etilevodopa hydrochloride
CAS No. 39740-30-2
Etilevodopa hydrochloride ( Etilevodopa HCl; ?L-DOPA ethyl ester; Levodopa ethyl ester )
Catalog No. M27765 CAS No. 39740-30-2
Etilevodopa HCl is a prodrug of levodopa. It also has greater gastric solubility and significant brain penetration.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 37 | Get Quote |
|
10MG | 59 | Get Quote |
|
25MG | 119 | Get Quote |
|
50MG | 177 | Get Quote |
|
100MG | 299 | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameEtilevodopa hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionEtilevodopa HCl is a prodrug of levodopa. It also has greater gastric solubility and significant brain penetration.
-
DescriptionEtilevodopa HCl is a prodrug of levodopa. It also has greater gastric solubility and significant brain penetration.
-
SynonymsEtilevodopa HCl; ?L-DOPA ethyl ester; Levodopa ethyl ester
-
PathwayOthers
-
TargetOther Targets
-
RecptornNOS/NOS1 AP
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number39740-30-2
-
Formula Weight261.7
-
Molecular FormulaC11H16ClNO4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCl.CCOC(=O)[C@@H](N)Cc1ccc(O)c(O)c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Wan-Hung Lee, et al. ZLc002, a putative small-molecule inhibitor of nNOS interaction with NOS1AP, suppresses inflammatory nociception and chemotherapy-induced neuropathic pain and synergizes with paclitaxel to reduce tumor cell viability. Mol Pain. 2018 Jan-Dec;14:1744806918801224.
molnova catalog
related products
-
GSK2256294A
GSK2256294A is potent, selective inhibitor of recombinant human, rat and mouse sEH with IC50 of 27 pM, 61 pM and 189 pM, respectively.
-
Methyl (E)-sinapate
Methyl (E)-sinapate is isolated from the Polygala sibirica L.var. megalopha Fr.
-
SL-327
SL327 is a selective inhibitor for MEK1/2 with IC50 of 0.18 μM/0.22 μM; able to transport through the blood-brain barrier.